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Abstract
Risk assessment for prostate cancer is challenging due to its genetic heterogeneity. In this
study, our goal was to develop an operational framework to select and evaluate gene variants
that  may  contribute  to  familial  prostate  cancer  risk.  Drawing  on  orthogonal  sources,  we
developed a candidate list of genes relevant to prostate cancer, then analyzed germline exomes
from 12  case-only  prostate  cancer  patients  from high-risk  families  to  identify  patterns  of
protein-damaging gene variants. We described an average of 5 potentially disruptive variants in
each individual and annotated them in the context of public databases representing human
variation. Novel damaging variants were found in several genes of relevance to prostate cancer.
Almost all patients had variants associated with defects in DNA damage response. Many also
had variants linked to androgen signaling. Treatment of primary T-lymphocytes from these
prostate cancer patients versus controls with DNA damaging agents showed elevated levels of
the DNA double strand break (DSB) marker  ?H2AX (p < 0.05),  supporting the idea of  an
underlying defect in DNA repair. This work suggests the value of focusing on underlying defects
in DNA damage in familial prostate cancer risk assessment and demonstrates an operational
framework for exome sequencing in case-only prostate cancer genetic evaluation.
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